Ostarine (MK-2866): Before and After Pictures, Side Effects & Dosage
Disclaimer: The following article is for educational purposes only and NOT to promote the use of illegal substances. If you have any questions or concerns, Dr. Touliatos is currently available for consultations.
Ostarine is a second generation SARM (selective androgen receptor modulator), also known as Enobosarm or MK-2866.
Ostarine was formulated to mimic the anabolic effects of steroids, but without the harsh side effects; thus theoretically providing a safer medication. The objective is for SARMs to improve the efficacy of treatment in patients suffering from cachexia, osteoporosis and anemia.
Ostarine (MK-2866) was first described in 2001 and developed by GTX Inc, a US biotechnology firm. Since then it has been evaluated in phase I, II and III clinical trials.
In two phase III trials, GTx announced that Ostarine was unsuccessful in the treatment of breast cancer patients (suffering from cachexia). This was due to insignificant improvements in muscular strength, despite increases in muscle hypertrophy (size).
This has led to the biotechnology company ceasing its pursuit of ostarine for the treatment of cachexia, but instead remaining committed to modifying MK-2866 for improved success in the future.
Due to Ostarine’s recent creation, it is not approved by the FDA for human-use, thus it is illegal to purchase for cosmetic purposes and is banned by sporting organizations, such as WADA.
Ostarine and other SARMs are classed as ‘investigative compounds‘ and are only allowed for scientific research.
This has led to SARMs manufacturers modifying their marketing strategy, labelling products as ‘research chemicals’ — instead of ‘dietary supplements’, effectively taking advantage of this legal loophole or gray area.
- 1 Ostarine Benefits
- 2 Ostarine Side Effects
- 3 Ostarine Results (Before and After Pictures)
- 4 Ostarine Before and After #2
- 5 Ostarine Before and After #3
- 6 Ostarine Dosage
- 7 Ostarine Cycle
- 8 Ostarine and Cardarine Stack
- 9 How to Take Ostarine
- 10 Ostarine PCT
- 11 Summary
Muscle Size & Strength
Ostarine mimics anabolic steroids’ anabolism, by stimulating the AR (androgen receptor), increasing skeletal muscle and bone strength.
Ostarine also enhances satellite cell cycle activation, resulting in fusing with myofibres and increasing myonuclei in the muscles.
Due to ostarine’s tissue selective properties it can increase lean muscle, without inducing the androgenic side effects of steroids — preventing benign prostatic hyperplasia (BPH).
In one study on elderly men and women, participants increased their lean body mass by 3%, after taking 3mg/day of ostarine for 12 weeks (1). This is the equivalent of an 80kg (176lb) man gaining 2.4kg (5.3lbs) of muscle.
These results are encouraging considering the dosage used (3mg/day) is only a fraction of what weightlifters administer to improve their body composition.
These elderly men and women also experienced significant increases in muscular strength, adding 22lbs to their bench press by the end of the 12 weeks.
No Virilization in Women
Women are particularly vulnerable to virilization effects when taking steroidal compounds, however ostarine appears to be safe in this regard; with elderly women in the above cited study experiencing no masculinization effects.
Ostarine is an effective SARM for cutting, due to it improving insulin sensitivity and thus inducing subcutaneous and visceral fat loss.
Reductions in visceral fat is a unique attribute with ostarine, in contrast to many anabolic steroids, which can increase VF.
This is why some steroid-users have a protruding appearance to their waistline, indicative of high visceral fat levels.
However, on ostarine you will notice fat loss all over the body, particularly prominent in the midsection; reducing overall waist size.
Ostarine also has positive metabolic effects, increasing calorie expenditure throughout the day and improving the chances of users eating in a calorie deficit. Thus, it has direct and indirect lipolytic effects.
In the elderly study, users experienced a 0.6kg (1.3lbs) reduction in fat mass. It is fair to assume this quantity of fat loss will be more pronounced in non-edlerly persons, who combine ostarine with regular weightlifting and cardiovascular exercise.
Ostarine Side Effects
Ostarine does not appear to cause hypertrophy of the prostate, however it does reproduce several steroid side effects (detailed below).
In the elderly study cited, the men taking 3g/day of ostarine for 12 weeks experienced minimal fluctuations in serum testosterone levels.
Weightlifters utilizing higher dosages of ostarine have reported normal libido, nocturnal erections and testicular size — when taking 25mg/day for 6 weeks (2).
However, other ostarine users have reported low testosterone levels post-cycle, with one user scoring 148 ng/dL, compared to an average score of 264-916 ng/dL (for his age range). This was following 20mg/day of ostarine for 8 weeks (3).
Thus, based on existing research and anecdotal evidence it is reasonable to conclude that ostarine has no significant effect on endogenous testosterone levels, when taken in very small dosages. However, in higher dosages it may have a significant suppressing effect; which may not always be obvious to users (unless being tested), and may depend on how the compound affects the individual (potentially differing on a case-to-case basis).
In the elderly study, AST/ALT liver markers increased above normal levels in 20% of participants, indicating ostarine’s hepatotoxic potential. Although levels did not rise to exceedingly dangerous levels, it is worth noting that such participants only took a fraction of the dose compared to gym-goers taking ostarine for physique-enhancing purposes.
Ostarine’s liver toxicity may be due to it being administered orally (swallowed via the mouth) and thus having to bypass the liver, before becoming fully active; increasing stress and inflammation to this organ.
HDL cholesterol (the good type), was reduced by 27% when taking 3mg/day of ostarine for 12 weeks. This is alarming, considering the tiny dosage used in this study; thus ostarine has the potential to increase myocardial infarction (heart attack) risk in the short or long-term — even in modest doses.
Ostarine and other SARMs’ ability to skew HDL/LDL cholesterol levels may be attributed to their oral nature; thus stimulating hepatic lipase in the liver upon entry — an enzyme known for decreasing HDL and increasing arterial plaque.
Gynecomastia and Water Retention
Some SARMs can elevate estrogen indirectly, with them binding strongly to the androgen receptor; leaving more natural testosterone available to convert to estrogen.
Consequently, some people have complained of bloating or gynecomastia when using SARMs, despite a lack of the aromatase enzyme present.
However, ostarine-users often report minimal water retention, but instead a dry-looking physique. Improved insulin sensitivity also indicates ostarine’s minimal effect on this female sex hormone; thus the risks of developing gynecomastia are thought to be low.
One user confirmed this by testing his estradiol levels post-ostarine cycle (5); they measured at a normal level, being 17.4 pg/mL (average range: 7.6-42.6 pg/mL).
Some ostarine-users do report hair loss or recession during their cycle (6), despite the 5-alpha reductase enzyme not being present with ostarine or other SARMs.
The reason hair loss occurs is due to elevated DHT (dihydrotestosterone) levels, which are raised indirectly. When ostarine competes with your natural testosterone levels for binding to the androgen receptor, ostarine wins — leaving higher amounts of free testosterone to convert to DHT. Although incidents of hair loss may not be as rife compared to anabolic steroids, androgenic alopecia is still possible on ostarine (and other SARMs).
Ostarine Results (Before and After Pictures)
This user’s results are after taking 20mg/day of ostarine for 45 days, in combination with regular weight training.
This user lost 3kg (7lbs) in weight, yet looks considerably more muscular, due to greater levels of muscle definition. Thus, the scales may not be an accurate indicator of results when taking ostarine; due to simultaneous muscle-building and fat loss. Before and after pictures therefore are a must when monitoring progress before/after cycles.
Note: These results may exceed the average person’s experience, as this user mentioned he had been training more regularly on ostarine, thus contributing to some of the muscle gain and fat loss.
Ostarine Before and After #2
This user lost 13lbs after cycling ostarine for 6 weeks. He administered 12.5mg/day during week 1, then 25mg/day for the remaining 5 weeks.
He reported zero side effects, at least to his knowledge, but experienced a notable amount of fat loss; accompanied by increases in muscle fullness and vascularity.
Note: Eating in a calorie deficit may have aided in some of the fat burning during this transformation.
He believes ostarine did not help him build any lean muscle mass, however it may contributed to muscle retention during his cut. His strength levels remained exactly the same during his 6 week cycle.
Ostarine Before and After #3
The above user lost 23lbs after an 8 week ostarine cycle, administering 20mg/day.
He adopted a calorie deficit diet during his cycle, contributing to substantial fat loss. He does not appear to have built any noticeable muscle mass, despite vast improvements in muscle definition.
He reports his strength staying the same, but crediting ostarine for preserving his size and strength whilst cutting on low calories (1800 calories/day).
In terms of side effects, he monitored his liver enzymes and testosterone post-cycle. His ALT liver enzyme score was high, being 57 IU/L (approximately 30% over maximum average levels).
His testosterone levels were also low, being clinically diagnosed with hypogonadism and eligible to be prescribed testosterone replacement therapy. He also reported: a crash post-cycle, feeling tired and having low well-being; despite not feeling a ‘high’ on-cycle.
Due to a lack of FDA approval, dosage guidelines have not been established for ostarine. However, in clinical studies 3mg, 9mg and 18mg/day have been utilized with some success.
Those taking ostarine to enhance their body composition commonly take 10-30mg/day.
Women often take the lower value of this range, being 10mg/day, in a bid to avoid virilization effects.
It is believed that higher dosages of ostarine may further promote muscle hypertrophy and thus be more effective as a lean bulking cycle, compared to lower dosages that predominantly enhance fat loss; thus being a cutting cycle.
However, higher dosages of ostarine may also exacerbate side effects, particularly cholesterol and liver values.
A common ostarine-only cycle, tailored for fat loss and muscle retention:
- 20mg/day of ostarine for 8 weeks
Note: The above cycle is commonly used by men. Women typically will administer 10mg/day for 4-8 weeks.
In some instances ostarine may be cycled for up to 12 weeks, however this is only suitable if cholesterol, liver and testosterone values have not excessively deteriorated from the first 8 weeks.
Ostarine can be cycled with other SARMs simultaneously, however this is not advised due to further elevations of blood pressure and liver enzymes.
Ostarine and Cardarine Stack
Some users commonly stack ostarine (MK-2866) with cardarine (GW501516) for enhanced results when cutting — specifically for more prominent fat loss.
Cardarine is not a SARM, but a PPARD (Peroxisome Proliferator Activated Receptor Delta) receptor agonist, and has a positive effect on insulin sensitivity and fatty acid oxidation; thus potentially helping to treat obesity in medicine.
Research has observed cardarine to significantly reduce fat mass, both in animal and human studies (7).
- Ostarine: 20mg/day for 8 weeks
- Cardarine: 20mg/day for 8 weeks
Medical research has also shown cardarine to have cardioprotective properties, increasing HDL cholesterol levels, and thus potentially reducing spikes in blood pressure from ostarine.
However, Dr. Thomas O’Connor has observed hepatotoxic effects from cardarine, based on his observation of patient labs in over 2,000 SARMs-users. He likens its adverse effects on the liver as to taking 50mg/day of anavar; thus stacking it with ostarine is likely to exacerbate liver values.
Cardarine is classed as a research chemical, similar to SARMs, due to its recent creation.
Cardarine first appeared in scientific research in 2001, thus its side effects are yet to be fully understood.
One concern with cardarine is its carcinogenic risk, with long-term animal studies showing a strong correlation with its use and various cancers.
People in the fitness community have criticized such studies, stating that excessively high dosages were utilized, however even the smallest dosage range proved to be carcinogenic. This includes a 5mg/kg dose, which when calculated across species, translates to a 65mg dose in an 80kg human.
This is somewhat close to the dosages utilized by fitness men and women today. Consequently, cardarine’s safety is in doubt and thus was pulled from further development in medicine in 2009.
How to Take Ostarine
Ostarine typically comes as an oral solution, dosed at 25mg/ml, and is taken by mouth.
Users can measure the dose in an eye dropper or syringe before placing it in the mouth.
Ostarine may also be taken sublingually, with the liquid being placed under the tongue for 10-15 seconds, before swallowing. Such placement allows the liquid to come into contact with the mucus membrane, creating a more direct and fast entry into the bloodstream.
This administration methodology also inhibits presystemic metabolism, increasing ostarine’s biological availability.
Ostarine is sometimes available in capsule form, with 10mg of ostarine typically being present in each tablet.
Ostarine is considered a mild SARM, thus complete shutdown of the HPTA (hypothalamic-pituitary-testicular axis) is unlikely.
However, notable suppression of testosterone is to be expected, thus a PCT is an option for ostarine users, depending on their symptoms and how hypogonadal they are.
If a user finds out their testosterone levels are on the low side, but their well-being, energy, testicular size and libido are normal; they may not utilize a PCT.
In this case it may take several weeks for their endogenous testosterone to return to previous levels.
If users are experiencing a crash in energy levels post-cycle and diminished sexual health, they may choose to run clomid post-cycle. Clomid is a mild medication, in comparison to Nolvadex, which is typically used for more potent SARMs or anabolic steroids.
Clomid will accelerate the recovery of the HPTA, helping to shorten the timespan of low testosterone symptoms.
As a PCT, clomid is typically taken at 25mg/day for 30 days.
A PCT for ostarine should begin 2 days after the last dose, with it having a half life of 14-16 hours; and thus will be fully cleared out of the body by that point.
At this time, ostarine (MK-2866) looks to possess potent fat-burning properties, due to its positive effects on insulin sensitivity and stimulation of the androgen receptor.
Lean muscle gains however are mild and should be considered inferior to more potent SARMs, such as LGD-4033 or RAD-140.
The severity of SARMs’ side effects are often understated and even mild SARMs (such as ostarine), present toxicity in relation to the heart and liver. Testosterone suppression is also likely to occur, leaving users temporarily hypogonadal.
In contrast, anavar, an oral steroid; may actually be safer than ostarine, with several decades worth of medical research documenting its effects. Anavar presents similar side effects to ostarine, in regards to: cholesterol alterations, raised liver enzymes and testosterone suppression; however these often are not problematic, hence its FDA approved status in medicine.
Thus, anavar’s risk to reward ratio may in fact be more desirable, compared to ostarine; especially as it will yield greater results, in terms of fat loss, strength and muscle gains.